File:EphedrineInBottles.jpg

摘要

ephedrine

In 1887 Nagajoshi Nagai (1845-1929), a Japanese researcher working in Germany, isolated ephedrine as the active ingredient of ma huang but found the substance to be highly toxic. In the 1920s, Chinese pharmacologist Ko Kuei Chen (1898-1988) and American pharmacologist Carl F. Schmidt (1893-1965), working at Peking Union Medical College, isolated ephedrine again. Chen and Schmidt, working with much smaller doses than Nagai, demonstrated ephedrine's value in treating heart disease and asthma. By 1927 Eli Lilly & Co. was manufacturing ephedrine on a large scale.

• Lilly Syrup No. 110, Ephedrine Sulphate, 1932
• Lilly Inhalant No. 20, Ephedrine Compound, 1932
• Swan-Myers Ephedrine Inhalant No. 66, ca. 1940

(Courtesy National Museum of American History, Smithsonian Institution)

Source: NIH: Government information at NLM Web sites is in the public domain.

许可协议

	此作品在美国属于公有领域，因为其是由美国政府的官员或雇员，基于其个人公务目的制作的作品，参考美国法典第17篇第1章第105条。 注意︰本模板仅适用于美国联邦政府的原创作品，不适用于任何美国州、属地、联邦个体、县、市或任何次级政府的作品。本模板也不适用于1978年以后由美国邮政署出版的邮票图案（参看美国版权局实践纲领第313.6(C)(1)条）。也不适用于部分美国硬币；参看美国铸币局使用条款。
本文件已被确认为免除已知的著作权法限制（包括所有相关权利）。

https://creativecommons.org/publicdomain/mark/1.0/PDMCreative Commons Public Domain Mark 1.0falsefalse